Loading verified market, valuation, and statement data.
2. Company Fundamentals
2.3 Management
| Role |
Metric |
| Consensus Rating |
N/A |
2.4 Return
| Metric |
Value |
| Expected Return (Ann.)* |
-8.20% |
| Risk / Std Dev (Ann.)* |
25.02% |
| 1-Year Price Return* |
-10.69% |
Latest Market Data (as of 2026-08-14, Hong Kong time):
| Metric |
Value |
| Last Price |
HK$4.14 |
| 52-Week Range |
HK$3.9 – HK$5.39 |
| Observation Count |
245 trading days |
The return and risk statistics use daily adjusted closes from the retrieved one-year price series and annualise daily moments using 252 trading days. The last price is the latest regular-market price reported for the stated date. Source: Yahoo Finance market data.
DuPont Model Analysis
The DuPont model decomposes return on equity (ROE) into three operating and capital-structure drivers:
ROE = Net Margin × Asset Turnover × Equity Multiplier
The comparison uses the latest two comparable annual periods available for the issuer, with reported statement amounts shown in HK$. Revenue and net income are income-statement flows; total assets and shareholders’ equity are year-end balance-sheet figures. This is a simplified year-end-balance DuPont comparison rather than an average-balance ROE calculation.
| DuPont component |
Calculation |
FY2025 |
FY2024 |
| Revenue |
Reported revenue |
HK$2.23B |
HK$2.19B |
| Net income |
Reported net income |
HK$112.29M |
HK$161.39M |
| Total assets |
Year-end reported balance |
HK$14.43B |
HK$13.50B |
| Shareholders’ equity |
Year-end reported balance |
HK$5.32B |
HK$5.18B |
| Net margin |
Net income ÷ revenue |
5.03% |
7.38% |
| Asset turnover |
Revenue ÷ total assets |
0.1549x |
0.1619x |
| Equity multiplier |
Total assets ÷ shareholders’ equity |
2.7095x |
2.6041x |
| ROE |
Net margin × asset turnover × equity multiplier |
2.11% |
3.11% |
Source: Yahoo Finance annual statements. Values are based on the two latest comparable annual periods returned by the source; fiscal period labels use the statement period-end year.
2.5 FCFF DCF Valuation
Valuation basis: This research model follows a five-year, unlevered FCFF DCF. It starts from reported annual operating inputs, forecasts revenue and operating cash conversion under an explicit mechanical policy, discounts FCFF at WACC, applies a Gordon-growth terminal value, and bridges enterprise value to an indicative common-equity value per share. It is an analytical estimate rather than a recommendation or personalised target price.
Step 1 — Forecast Operating Profit and NOPAT
| Reported operating input |
Value |
| Revenue |
HK$2.23B |
| Prior annual revenue |
HK$2.19B |
| EBIT |
HK$556.09M |
| Tax rate |
40.00% |
| NOPAT = EBIT × (1 − tax rate) |
HK$333.66M |
| Forecast start-growth basis |
2.23% |
| Forecast policy |
latest reported annual revenue growth, bounded to -10.00% / 15.00% |
Step 2 — Calculate FCFF
| Current FCFF building block |
Value |
| NOPAT |
HK$333.66M |
| Add: depreciation & amortisation |
HK$246.63M |
| Less: capital expenditure |
-HK$67.65M |
| Less/(add): working-capital cash-flow movement |
-HK$7.80M |
| Current unlevered FCFF |
HK$504.84M |
Explicit FCFF forecast
| Forecast year |
Revenue growth |
NOPAT |
D&A |
Capex |
Change in NWC |
FCFF |
Present value |
| 1 |
2.23% |
HK$341.10M |
HK$252.12M |
-HK$69.16M |
-HK$7.98M |
HK$516.09M |
HK$501.49M |
| 2 |
2.30% |
HK$348.94M |
HK$257.92M |
-HK$117.54M |
-HK$8.16M |
HK$481.15M |
HK$441.46M |
| 3 |
2.36% |
HK$357.19M |
HK$264.01M |
-HK$168.22M |
-HK$8.35M |
HK$444.63M |
HK$385.19M |
| 4 |
2.43% |
HK$365.87M |
HK$270.44M |
-HK$221.37M |
-HK$8.56M |
HK$406.38M |
HK$332.42M |
| 5 |
2.50% |
HK$375.02M |
HK$277.20M |
-HK$277.20M |
-HK$8.77M |
HK$366.25M |
HK$282.88M |
Step 3 — Determine the Discount Rate (WACC)
| WACC input |
Value |
| Risk-free rate |
4.71% |
| Equity risk premium assumption |
5.50% |
| Beta |
0.51 |
| Cost of equity |
7.54% |
| Pre-tax cost of debt |
4.55% |
| WACC |
5.91% |
| WACC validation |
requires assumption review |
Step 4 — Estimate Terminal Value
| Terminal-value input |
Value |
| Perpetuity growth rate |
2.50% |
| Terminal value |
HK$11.01B |
| Implied terminal EV / EBITDA |
12.21x |
| Terminal value as % of enterprise value |
80.97% |
Step 5 — Discount Cash Flows to Enterprise Value
| Enterprise-value component |
Value |
| Present value of explicit FCFF |
HK$1.94B |
| Present value of terminal value |
HK$8.27B |
| Indicated enterprise value |
HK$10.21B |
| Discounting convention |
mid-year for explicit FCFF; terminal value discounted at year-end five |
Step 6 — Convert Enterprise Value to Equity Value
| Equity bridge |
Value |
| Indicated enterprise value |
HK$10.21B |
| Less: gross interest-bearing debt |
HK$7.65B |
| Add: cash and equivalents |
HK$2.54B |
| Add: affiliate investments |
HK$0.00 |
| Less: minority interests |
HK$275.67M |
| Indicated common equity value |
HK$4.83B |
Step 7 — Calculate Indicative Value Per Share
| Per-share output |
Value |
| Shares used |
3,588,437,000.00 |
| Share-count basis |
reported diluted weighted-average shares |
| Current market price |
HK$4.20 |
| DCF indicative value per share |
HK$1.35 |
| Indicative value vs. market price |
-67.91% |
Model Integrity Checks
| Check |
Result |
| Perpetuity growth is below the risk-free rate |
pass |
| Perpetuity growth is below WACC |
pass |
| WACC is within the configured operating-company range |
review required |
| Terminal-year FCFF is positive |
pass |
| Terminal capex converges to D&A |
pass |
| Terminal-value concentration |
within review band |
| Implied price differs from spot by more than 30% |
review required |
2.6 Investor-Style Research Screen
| Educational screen |
Result |
| Buffett-inspired cash-quality checks |
2/4 evidenced checks |
| Lynch-inspired balance-and-growth checks |
3/4 evidenced checks |
Data lineage: Yahoo Finance public market and reported-statement data; retrieval timestamp: 2026-08-18 16:07:39.948058 UTC; latest reported fiscal period: 2025-12-31 00:00:00. Default assumptions: five-year forecast, mid-year discounting for explicit FCFF, a maximum 2.50% perpetuity-growth rate below both WACC and the risk-free rate, historical operating-ratio persistence, and capex convergence to D&A by year five. No sell-side consensus or management guidance is substituted for reported inputs. This is research and analysis only, not personalized financial advice.
2.7 Quantitative Factor Diagnostics
Model basis: Daily issuer USD excess returns are regressed in-sample using ordinary least squares on matching regional Fama–French factors. FF3 estimates market, size, and value loadings; FF5 adds profitability and investment. Coefficients are descriptive historical exposures, not predictions.
| Estimation input |
Value |
| Regional factor set |
Asia Pacific ex Japan |
| Factor-return currency |
USD |
| Issuer-return basis |
USD adjusted total return |
| Estimation window |
2025-08-20 to 2026-06-30 |
| Aligned daily observations |
210 |
| Minimum observation requirement |
120 |
| Currency conversion for HK listings |
HKD adjusted close divided by daily USD/HKD close before simple daily return calculation |
Fama–French Three-Factor and Five-Factor Results
| Diagnostic |
FF3 |
FF5 |
| Annualised alpha |
-23.38% |
-24.52% |
| Adjusted R² |
0.16 |
0.19 |
| Annualised residual volatility |
22.12% |
21.51% |
| Factor loading (t-statistic) |
FF3 |
FF5 |
| Market excess return (Mkt-RF) |
0.78 (6.18) |
0.92 (6.91) |
| Size (SMB) |
0.21 (1.15) |
0.53 (2.33) |
| Value (HML) |
0.29 (1.66) |
0.05 (0.24) |
| Profitability (RMW) |
NM |
-0.42 (-1.73) |
| Investment (CMA) |
NM |
0.78 (2.86) |
Definitions: Mkt-RF is the market return less the risk-free rate; SMB is small minus big; HML is high minus low book-to-market; RMW is robust minus weak profitability; CMA is conservative minus aggressive investment. Factor returns are sourced from the Kenneth R. French Data Library; issuer adjusted-return history is sourced from Yahoo Finance. For Hong Kong listings, adjusted HKD prices are converted into USD with daily USD/HKD closes before return calculation to match the USD regional factor basis. This is an in-sample historical regression; coefficients and t-statistics do not establish causation or predict future returns. This is research and analysis only, not personalized financial advice.